Considerable progress has been made in the understanding of the formation of gastric erosions by the use of animals. The role of gastric acid secretion in their pathogenesis has been clarified. Gastric erosions are associated with the presence of acid in the stomach and slow gastric contractions. With several different experimental procedures, the animal's body temperature falls; preventing the fall averts erosions. A fall in body temperature or exposure to cold are associated with the secretion of thyrotropin-releasing hormone (TRH), and both increased and decreased concentration of corticotropin-releasing factor (CRH) in discrete regions of rat brains. Thyrotropin-releasing hormone when injected into specific sites in the brain produces gastric erosions and increases acid secretion and slow contractions, whereas CRH has the opposite effects. One of the major sites of interaction of the two peptides is in the dorsal motor complex of the vagus nerve. Thyrotropin-releasing hormone increases serotonin (5-HT) secretion into the stomach. Serotonin counterregulates acid secretion and slow contractions. Many other peptides injected into discrete brain sites stimulate or inhibit gastric acid secretion.
INTRODUCTION
Pavlov pioneered the use of dogs to describe the mediating role of the vagus nerve in gastric acid secretion, the anticipatory ("psychic") phase of secretion, and its conditioning. And, Selye produced gastric erosions in rats by a very large number of injurious and noninjurious (such as restraint) agents.
Ever since then, animals have been used to explore two related themes: a) the central (brain) regulation of gastroduodenal function and b) the pathogenesis of gastroduodenal erosions. These two topics can, of course, be related when experimental procedures have been devised to alter the appropriate regulatory brain mechanisms either by making electrolytic lesions in, by stimulating discrete areas of the brain, or injecting areas with active agonistic or antagonistic substances. A long tradition also exists of producing erosions, not by a direct approach to the brain, but by a large number of experimental procedures (conceived of as "stressful"), many of which, however, do not occur in the natural life of the animal.
Reliable animal models of disease have revised our understanding of the multifactorial nature and complexity of human gastroduodenal erosions (1) , and have lead to a variety of improvements in treatment to reduce gastric acid secretion, or enhance gastric mucosal resistance.
However, two caveats must be made: a) the validity of erosion formation produced in rats for our understanding of the pathogenesis of human gastroduodenal ulcers has continued to be questioned; and b) the discovery of the key (ie, local) role of Helicobacter pylori infection in human ulcer disease, has seemingly trivialized the part played by stressful experience mediated by the brain in its pathogenesis. (I shall return to this topic later in this report.) Experimental Methods to Produce Gastric Erosions Restraining rats by wrapping them in wire mesh, placing them in a tight-fitting tube, or tying them to a board has been a traditional method of producing gastric erosions (2) (3) (4) (5) (6) (7) (8) (9) . Usually, animals were not fed 24 hours before or during the procedure.
Initially, the validity of the model for human disease was questioned, because the erosions produced by some forms of restraint, especially when associated with food deprivation, tended to be in the rumen of the stomach (10), whereas those in the glandular portion did not usually penetrate to the muscularis mucosa (11). However, this limitation was overcome by the careful control over the experimental design (eg, production of complete immobilization, reduction of the time of food deprivation before restraint), to produce true ulceration (12). Therefore, the aim of inciting gastric erosions that were the analogue of the human lesion was attained by the total immobilization of the animal.
The restraint technique (combined or not with exposing the animals to cold or water), or electrical shocks applied to the tail or feet, and other such painful procedures, are experimental artifacts. The animal could not predict, prevent, avoid, or escape intermittent or continuous electric shocks, regularly or randomly administered. But the effects on an animal that could predict the onset of signaled shocks differed from those that could not. The extent of the gastric erosions produced was six times greater in rats that received shocks to the tail that were not regularly paired with a warning tone, than in those exposed to shocks that were signaled.
When a rat could learn to avoid receiving shocks by turning a wheel that switched off the current, the number and extent of gastric erosions were reduced when compared with experimental animals that were not provided with one (13). The turning-off of the current could also be made to coincide with another brief electric shock-the animal was punished for its attempts to avoid the initial shock. When this procedure was followed, rats developed even more extensive gastric erosions when compared to those of a yoked, unpunished partner. Conversely, animals that could not prevent receiving shocks, but were allowed to maul a neighboring rat, developed fewer gastric erosions (14) . If the rat was allowed a choice between predictable and unpredictable shock, it "elected" the former and had fewer gastric erosions (15).
These experiments illustrate important principles not originally predicted. Preventing or avoiding a painful or stressful experience reduced its damage; punishing attempts to do so maximized its effects.
During the 1950s and 1960s (16) some of the physiological correlates of restraint and other experimental procedures were clarified. For example, vagotomy reduced and adrenalectomy increased the incidence of erosions in rats (6, 11).
The complex interactions that influenced erosion formation were attested to by the fact that genetically determined factors-variations in levels of serum pepsinogen in rats-or the time of day restraint was applied, also played a role in the incidence of lesions. These variables could, however, be made irrelevant if restraint was maintained for a prolonged period-when it became the prepotent variable. Ader (17) (18) (19) showed that the distribution of values for serum pepsinogen levels in populations of rats and humans were similar. Considerable differences in mean values occurred between and within various strains of rats. Male rats of the Osborne-Mendel strain had the highest, and those of the Wistar strain the lowest, values. Female rats of each of four different strains tended to have higher values of serum pepsinogen than male rats of the same strain, but differences between strains were less apparent in females.
The role of variations in pepsinogen levels was revealed only when rats were restrained. The reason for this was that the location in the stomach of the erosions depended in part on the nature of the stressful experimental procedure. When rats were subjected to restraint with minimal food deprivation, the lesions were largely confined to the body of the stomach (20, 21) . No relationship could be found between serum pepsinogen levels and erosion formation in the rumen of the rat's stomach. The body of the rat's stomach secretes acid and pepsin. About 29% of restrained animals, which fell into the highest 15% of the distribution of serum pepsinogen levels, were more susceptible to erosion formation in the body of the stomach, than those whose levels were in the lower 15% (19).
The values for serum pepsinogen levels in rats were not fixed. Restraint lowered high, and increased low, basal pepsinogen levels. Circadian variations in such levels also occurred, which corresponded with the activity cycle of the animal, being higher at the beginning of the night and lower during the day when rats were asleep. Restraining rats for 6 hours at the peak of the activity cycle was associated with gastric erosions, which did not occur when restraint was applied at its nadir (17). But the circadian variation in pepsinogen levels did not seem to account for the results of this second procedure (21). Corticosterone levels rose before nightfall and then fell. Despite the fact that restraint increased corticosterone levels in the rat, their circadian variations did not seem to play a role in the formation of erosions (22).
This second group of studies reopened the question of the part played by the corticosteroids in the formation of gastric erosions. In fact, the role of the corticosteroids in gastric erosion formation has still remained unsettled. The fact that procedures, such as prolonged restraint (with or without exposure to cold) or unavoidable electrical shocks, were both followed by their secretion and by the formation of erosions, does not mean that their positive correlation was a causal one. Murphy et al. (23), and Weiss (24-26) suggested that it was likely to be so. But erosions occurred even when adrenalectomy was followed by restraint (7); in fact, their incidence was increased! No correlation could be found in less prolonged experiments using restraint; in fact, an inverse relationship between corticosteroid levels and erosion formation existed when a "backward" form of Pavlovian conditioning was employed (27) (eg, the physiological stimulus was delivered just before the neutral cue). At present, it is likely that the correlation between erosions and raised corticosteroids levels is a temporal one.
Therefore, one must conclude that Selye's proposal that corticosterone played a primary pathogenic role in erosion formation was not likely to be correct. In part, it was predicated on the fact that in large doses the corticosteroids may be ulcerogenic in the rat (28) and in humans. The corticosteroids are known to inhibit prostaglandin (PG) secretion, which protects the gastric mucosa against erosions (29).
The Roles of Prior Experience, Gastric Acid Secretion, and Body Temperature in Gastric Erosion Formation A third group of experiments (30-37) led to revised concepts about the roles of prior experience as a risk factor for, and of increased gastric acid secretion in, the formation of erosions (32). These experiments also highlighted the critical role of a fall in body temperature before the development of gastric erosions, during many experimental procedures designed to produce them.
Male rats when prematurely weaned at 15 days, and when placed in an experimental conflict situation for variable periods of up to 4 weeks, at 120, 200, and 260 days of age, all developed rumenal ulcers; the females did not (21). Undetermined nutritional factors predisposed male rats to erosions and were postulated to mediate the effects of premature weaning (33, 34).
Erdos6va and her colleagues (35) reported that male rats, before sexual maturity, when weaned at 16 days of age and then later immobilized at various ages, were more susceptible to gastric erosions in the body of the stomach. Sexually immature rats had a significantly higher incidence of lesions than rats who weaned themselves at 21 days. However, no further investigations were carried out to determine the reason why premature weaning should create a "window of susceptibility" to erosion formation during restraint.
Prematurely separated rats, when restrained or not fed (or both), at 22, 30, and 40 days of age developed erosions in the glandular portion of the stomach with an incidence of 80-95% (36). (The incidence in normally weaned animals of the same age is 10%.) This effect was mediated by a fall in body temperature during restraint or food deprivation (30). Maintaining the body temperature of restrained rats averted the lesion. The animals did not ulcerate when restrained at 17 days of age. After 40 days of age, the incidence of gastric erosions progressively declined in separated animals when restrained; by 200 days of age it was 20%. The effects of a challenge in prematurely separated animals was, therefore, age-dependent. The initial separation did not produce erosions but placed them at profound risk for the lesions on subsequent challenge at a later age (of 22-40 days) but not at all ages.
An incapacity to maintain body temperature after separation was manifested only on challenge, and was not observed when the animal was left to its own devices in an environment whose temperature was about 20°C. The disturbance in body temperature regulation was originally brought about by depriving the animal of its mother's milk. If young separated rats were enabled to lap up milk, their body temperature was maintained when restrained (32).
Prematurely separated rats were permanently underweight. They also stored less brown fat; when restrained, the stores were more rapidly depleted than those of their normal peers. As a consequence their body temperature was not maintained as in normally weaned animals (37).
Cooling normal rats artificially in order to produce a fall in body temperature linearly induces increased gastric acid secretion. But when 30-day old, prematurely separated rats were cooled so that their body temperature fell to 29°C, they actually secreted less hydrochloric acid than did nonseparated rats (32, 37).
When mature male rats of the same age, representing seven different rat strains, were food-deprived and then subjected to restraint in water maintained at 18.5°C, all rapidly showed a fall of body temperature of 5 to 8°C. Members of certain strains (LongEvans, Wistar Kyoto, and Fisher-344) had a higher incidence of erosions. They also all showed a much slower recovery to normal body temperature than did members of other strains (eg, Lewis, Wistar) (38). One may conclude that a fall in body temperature and recovery from it were important variables in mediating the effects of restraint and/or cold. In fact, it is now possible to classify the many different procedures used to produce gastric erosions into two main groups: a) those associated with a fall in core body temperature: ie, restraint, immobilization in water (whether cold or not), a low ambient temperature, premature separation followed by restraint, increased motor activity produced by feeding the animal once daily (39), and so forth and b) those that promote an increase in body temperature: ie, pro-longed, unavoidable electric shocks (40) and lateral hypothalamic lesions (41).
The recognition that a fall in body temperature was the consequence of a number of experimental manipulations, culminating in gastric erosions, was a direct indication of the participation of the brain in the pathogenetic process. Before that time it was not certain that the effects of restraint required the brain's involvement, especially as increased corticosteroid levels, when they occur, were temporal, not causal, correlates of the procedure. (They were believed to rise as a result of the release of adrenocorticotropin (ACTH).)
The Activity Stress Model Placing rats in a cold environment for 2 to 3 hours understandably lowered their body temperature, but it has not been so clear why merely immobilizing them also did so. When restrained they did not struggle; in fact, they initially fell asleep (31). Of course, immobilization interfered with motor activity-but only when applied at the peak of the circadian activity cycle were gastric erosions produced (22).
Increasing the motor activity of rats by the simple maneuver of feeding them for 1 hour once a day and giving them free access to run in a wheel markedly increased their motor activity (39). As 4-5 days passed, some rats progressively ran more and more, lost body weight, and died. At autopsy, large gastric erosions were found. In addition, a number of other physiological changes occurred before death: corticosteroid levels were high, testosterone levels fell, and in those animals which died the body temperature fluctuated wildly by 6-9°C in any 24-hour period (42). When no such fluctuations were observed, rats survived. But neither food restriction nor enhanced activity by themselves produced gastric erosions (39). Nor, could it be concluded that gastric erosions preceded the rats' increased motor activity (43). The critical variable preceding gastric erosion, seemed to have been a disregulation of body temperature. Furthermore, a combination of increased gastric contractions (44) and acid secretion, mediated in part by histamine and its H-2 receptor, seemed to initiate gastric erosions (43).
The Proximate Mechanisms of Gastroduodenal Erosions: The Role of Gastric Hydrochloric Acid Secretion The recognition that a fall in body temperature was a critical variable associated with several experimental procedures, which produced gastric erosions, explained the effects of several different procedures and unified a number of disparate observations (30, 32, 45, 46). Cold restraint usually increased gastric acid secretion (46, 47) mediated by the release of histamine in the stomach and by H-2 receptors under vagal influence (48, 49) .
Increased gastric acid secretion, until recently, has been held to be mainly responsible for the formation of gastric erosions, despite the fact that it had long been known that lesions did not necessarily occur with exposure to cold, or to cold restraint (9, 50, 51).
In the 30-day-old, prematurely weaned rat, cooling produced an average fall in body temperature of 8°C, but such a rat actually secreted less hydrochloric acid into the lumen of the stomach than did its nonseparated peers. In addition the response of prematurely separated rats to various secretogogues was virtually the same as that of normal rats of the same age (32).
Exposure of normal rats to unavoidable electric shock did not increase acid secretion (52); gastric erosions still occurred in them with cold restraint, during which acid secretion was partially suppressed (53, 54) . However, when acid secretion was totally inhibited by cimetidine or ranitidine, cold restraint was not associated with erosion formation (54) . Thus acid in the stomach played a permissive role in erosion formation; it needed to be present in some amounts, but by itself it did not suffice to incite
The Role of Gastric Contractions in the Production of Gastric Erosions About the time that the role of hydrochloric acid secretion in the pathogenesis of experimental erosions was clarified, changes in gastric contractions during stressful experience were beginning to be given serious consideration.
A technique for measuring contractions by means of miniature strain-gauge force transducers attached to the external wall of the stomach was devised (40, 53, 55, 56) . By this method, stressful experiences of several kinds were shown to produce a pattern of slow (0.5-2/minute or less), relatively regular rhythms in all parts of the stomach (53) . The wave form and frequency (6-7/minute), but not always the amplitude, of the regular feeding pattern of contractions differed from the slow ones.
The slow contractions were incited by lowering the body temperature (56) , during cold restraint (53, 56) , with predictable and unpredictable electric shocks (40), in the restrained, prematurely separated, 30-day old rat, and after the placing of lateral hypothalamic: lesions (58) . The slow contractions outlasted the procedure for as long as 2 hours (40). They were invariably associated with erosion formation. Only by their complete suppression (without altering gastric acid secretion) during cold restraint by pretreating rats with papaverine (50-100 mg/kg) were erosions averted (53, 59) .
A transition in the rhythm of gastric contractions, usually associated with feeding, occurred when preceded by a variety of stressful procedures (including a fall in body temperature), and seemed to be another necessary condition in the pathogenesis of gastric erosions in rats, especially, and if combined with the presence of a certain amount of hydrochloric acid in the stomach lumen.
However, the manner in which persistent, slow contractions might contribute to the production of erosions has remained controversial. They may predispose to reduced blood flow and patchy hypoxemia in the gastric mucosa (60-62). As more accurate methods have been developed for the measurement of mucosal blood flow while recording gastric contractions during cold restraint, this hypothesis has not been substantiated (63) . In fact, other investigators have suggested that the slow contractions directly and mechanically injure the mucosa (64) .
The two variables-gastric acid secretion and contractions-normally covary (55, 65) in rats and in humans. What remains to be seen is whether their covariance is altered in human beings as in rats, during stressful experiences.
Changes in motility and acid secretion are not the only ones to play a role in erosion formation-for example, diminished HCOJ secretion in the stomach and/or duodenum have been described. The combination of four factors-increased acid secretion, slow contractions, rapid gastric emptying, and diminished duodenal HCOJ secretion-produced duodenal ulcers in rats, when injected three times with histamine (40 mg/kg) during a period of cold restraint (66) . The most likely explanation of the formation of gastroduodenal ulceration was that, in the presence of increased amount of hydrochloric acid, slow, persistent gastric contractions accelerated gastric emptying. Acid entered the duodenum, backdiffused into die duodenal mucosa, whose first line of defense (HCOJ) had been reduced. This "local" end process was not linear but interactive, requiring a minimum of four variables; it could be averted by anticholinergic agents and bilateral vagotomy (51, 56, 57) . Therefore, in the past 15 years, one of the key questions being investigated was: How does a stressinduced fall in body temperature mediated by the vagus nerve produce slow contractions, changes in acid secretion, and gastric erosions?
Regulation of Gastric Acid Secretion Clinicians focus on the proximal mechanisms of gastroduodenal ulceration-in particular on excessive gastrin and, therefore, gastric acid and pepsin secretion with gastrinoma or H. pylori infection, and on decreased mucosal "defense" due to the inhibition of PG synthesis by nonsteroidal anti-inflammatory drugs. Physiologists are, however, interested in the regulation of acid secretion and its disturbances.
Some but not all the interacting, regulatory factors are displayed in Figure 1 . A simple function-acid secretion by the parietal cells of the stomachdepends on neural (vagal-cholinergic), endocrine (gastrin), and paracrine (histamine) stimulation. However, pepsinogen secretion from the chief cells is regulated by gastrin and histamine. As the figure also shows each is stimulated or inhibited by the other, as well as by additional local (gastric) and neural and endocrine factors emanating from medullary vagal and raphe nuclei, sympathetic neurons, pituitary hormones, and specific hypothalamic and (not shown) limbic areas. The number of variables displayed in Figure 1 would alone generate a minimum of 36 possible interactions. Yet the figure does not display the regulation of gastric motility, mucus production, or mucosal cell turnover. Although it may very well be that, in some forms of human ulcer disease, increased pepsin and gastric acid secretion together, and diminished HCOJ production play the most important pathogenetic roles, the fact is that they may each come about by means of diverse distal regulatory disturbances.
THE ROLES OF BRAIN PEPTIDES AND THE VAGUS NERVE IN THE FORMATION OF GASTRIC EROSIONS
Beginning in 1980, several lines of evidence began to converge that pointed to the role of the tripeptide, pyro-Glu-His-ProNH 2 (TRH), in mediating the stressinduced fall in body temperature to alter the functions of the stomach, and to produce gastric erosions. They were as follows:
1. Intracerebroventricular (ICV) TRH in picomolar doses stimulated gastric acid secretion (67, 68) , and intracisternal (IC) TRH promoted gastric emptying (69) , pepsin secretion (70) (71) (72) , and also produced gastric erosions (69, 71, 72, 75) . But injections at these sites did not reveal where in the brain TRH acted to produce these effects.
2. Exposing rats to an ambient temperature of 4°C increased the content of TRH 5-to 10-fold in the median eminence and in third ventricular fluid (76, 77) . The release of TRH by cold, and presumably by a fall in body temperature, was mediated by a aadrenergic receptors (78) . In addition to maintaining and regulating the secretion of thyrotropin (TSH) tonically, TRH also regulated short-term, phasic responses (79, 80) in TSH to cold.
3. TRH is widely distributed in the brain. Twelve percent of the brain's total content of this peptide was present in the brain stem, especially in the dorsomotor nucleus of the vagus nerve (DMV), the nucleus ambiguous (NA), and the nucleus tractus solitarius (NTS) (81) , where nerve terminals containing TRH and receptors for it were found (82) (83) (84) . The medullary sites of the cell bodies of the TRH containing neurons and terminals in the DMV and NA were the nuclei raphe pallidus, magnus, and obscurus (81, (83) (84) (85) (86) .
The DMV contained the cell bodies of preganglionic neurons of the vagus nerve to the stomach (87, 88), in particular to the antrum and pylorus in the cat (85) . Cutting the vagus nerve abolished all the effects of ICV or IC TRH (72, 89, 90) , which were also partially blocked by atropine (69, 74, 75, 91) .
Site of Action of TRH in the Brain Stem: Its Role in Gastric Acid Secretion Therefore, a number of clues pointed to the DMV and NA as the likely brain stem sites of action of TRH in promoting efferent vagal activity, in regulating gastric function, and in the formation of gastric erosions. Injection of TRH in doses of 1 to 10 pmol (0.4-4.0 ng) increased gastric acid secretion (92, 93) when injected into the DMV of rats, but it had no effect if injected into the area postrema or a variety of other medullary nuclei.
The action of TRH in these experiments was very brief. The tripeptide is known to be rapidly cleaved by endopeptidases into several metabolites-pyroGlu-His-Pro, pyro-Glu-His-Pro-OH, pyro-Glu-His, and cyclo(His-Pro)-none of which were active in promoting acid secretion (94). The effective dose and action of a stable, synthetic analogue, pyro-GluHis(3,3' dimethyl)-ProNH 2 (Rx 77368), was the same as TRH but lasted much longer when injected IC (94, 95). RX 77368 in doses of 10-100 ng injected into the DMV, NTS, and NA produced a dose-dependent increase of gastric acid output which slowly built up and attained a plateau level 40 minutes after injection. The secretory response was abolished by vagotomy (94, 96, 97).
Co-secretion of TRH and Serotonin Thyrotropin-releasing hormone is co-localized with serotonin (5-HT) and substance P in the nucleus raphe' obscurus (98). Pretreatment of rats with a 5-HT reuptake inhibitor given IV or IC potentiated gastric acid secretion induced by IC RX 77368 (99). When TRH or analogue and 5-HT were injected in that order into the DMV, both gastric motility (100) and acid secretion were enhanced over the levels attained by injecting RX 77368 alone (101). Serotonin was released at the DMV by stimulating the nucleus raphe' obscurus with kainic acid but only in fed and not in fasted rats. Because bilateral vagotomy abolished the release of 5-HT in fed rats, it was believed that reflex vagal afferent activity stimulated by food in the stomach, interacted with efferent discharge from raphe" neurons (102).
The Release of Gastric Serotonin and Hydrochloric Acid by TRH Vagal stimulation (102-104) increased the gastric acid and the 5-HT content of the stomach in rats and cats. But the exact reasons for this correlated phenomenon did not become clear until later (97, 105, 106), although it was known that systemic administration of 5-HT inhibited stimulated gastric acid secretion (107, 108) and diminished the motility of the stomach (109, 110). But the action of endogenously released 5-HT (presumably from enterochromaffin, enterochromaffin-like and mast cells, and enteric neurons in the stomach) was unknown.
The IC injection of RX 77368 (100 ng) produced a dose-dependent tripling of gastric acid secretion, but also a 9-to 10-fold increase of 5-HT content of the lumen of the stomach. Gastric acid secretion after 3 to 30 ng of RX 77368 IC could be increased by an additional 43% after the stomach's content of 5-HT was depleted by 66%, and 5-HT secretion into the lumen fell by 57%, after pretreatment of the animal with p-chlorphenylalanine (p-CPA) (300 mg/kg)-an inhibitor of tryptophan hydroxylase. However, p-CPA also depleted the whole brain of 5-HT by 95%. Therefore, increased gastric secretion subsequent to IC RX 77368 injection could not initially be ascribed to a reduction of the gastric secretion of 5-HT. However, when central but not gastric stores of 5-HT were depleted by the neurotoxin, 5',7'-dihydroxytryptamine (5',7'-DHT), while the brain's noradrenergic neurons were protected against its action by desipramine, no enhancement of gastric acid secretion after IC RX 77368 occurred. 5',7'-DHT reduced whole brain 5-HT by 57% without changing the stomach's content. Even when 5',7'-DHT was combined with another neurotoxin, p-chloroamphetamine, to reduce brain 5-HT content by another 7%, the gastric secretory response to RX 77368 remained unchanged (97, 106). The exact sites of action in the brain stem of RX 77368 in stimulating 5-HT secretion in the stomach were the same ones that enhanced gastric acid secretion-the DVM and NTS, and the NA-but not other sites in the medulla. Thirty nanograms of the peptide analogue injected into the DVM increased the secretion rate of 5-HT 13 times (ill).
Therefore, one may conclude that 5-HT secretion into the stomach was stimulated by vagal efferent discharge (it was blocked by pretreatment with atropine), and counter-regulated gastric acid secretion in the stomach. Curiously enough, gastric acid secretion when provoked by peripherally administered pentagastrin, histamine, or a cholinergic agonist (bethanechol) was not further enhanced when the stomach was depleted of 5-HT by p-CPA (97, 106). Thus the counter-regulatory effect of 5-HT on gastric acid secretion depended on their both being centrally and simultaneously stimulated.
Not only did p-CPA pretreatment enhance acid secretion but it also doubled the gastric contractile response produced by IC RX 77368 (100 ng). In contrast, administration of. 5',7'-DHT did not (97, 106).
The Vagal Control of Gastric Acid Secretion and the Role of TRH Even such a simple function as gastric acid secretion is under complex regulatory control. Increased vagal efferent activity stimulated electrically produced the release of gastrin (counter-regulated by somatostatin (STS)), of acetylcholine acting via a M 1 muscarinic receptor, and of histamine mediated by H-2 receptors, and opposed by STS. The fact that injection of TRH and its analogue increased gastric acid secretion in rats was supported by the observation that the firing rates of vagal efferent neurons were increased by RX 77368 microinfused into the DMV (112, 114, 115). But, curiously, RX 773688 (15 ng) increased gastric acid secretion only through the release of acetylcholine and histamine, acting through their respective receptors; no gastrin was secreted (115).
Differential Effects of TRH and STS on Gastric
Acid and Serotonin Secretion: Not Only Vagal Control There seems to be no limit to the complexity of the system being described! Although 5-HT potentiated the effects of TRH in exciting vagal efferent neurons arising in the DMV, it counter-regulated the effects of vagal stimulation on gastric acid secretion. Somatostatin inhibited the effects on local gastrin-and histamine-stimulated acid secretion, but its analogue promoted acid and 5-HT secretion by the stomach when injected IC. Surprisingly, however (and obviously in contrast to TRH analogue), it inhibited the release of 5-HT by the stomach (116). Furthermore, it seemed that gastric 5-HT secretion produced by a TRH analogue was not only mediated by increased vagal discharge but by adrenal catecholamines. In fact, STS suppressed such catecholamine secretion incited by TRH (117).
TRH and the Stimulation of Slow Gastric Contractions To recapitulate, restraining rats in the cold (and other standard stressful experiences) was invariably associated with slow, irregular (high amplitude), long-lasting gastric contractions and gastric erosions, which were also associated with a fall in body temperature of 8-12°C (118). Intracisternal TRH (1 jug) or RX 77368 (0.3-30 ng) stimulated these slow contractions in awake rats, which could be abolished by bilateral vagotomy (90), and were associated with gastric erosions (71, 73, 74, 91) . The site of action of TRH and its analogue were exactly the same as those that stimulated increased acid secretion. Once stimulated, the contractions lasted for 1 hour (119, 120). Injection of control sites in the medulla-the hypoglossal nucleus and the lateral reticular nucleushad no effect (119).
In summary, TRH and RX 77368 injected into specific medullary sites known to contain TRH nerve terminals and receptors (83, 84) in the rat and cat (85, 121) simulated the effects of cold restraint. The stimulatory effects of TRH on gastric acid secretion and contractions were independent of TSH secretion (70, 85) or changes in blood pressure and heart rate (85) .
The fact that TRH and its analogue promoted both acid secretion and slow contractions, and produced gastric erosions in rats, has not proven that cold restraint or other procedures released the tripeptide from known sites (eg, the DMV) in the medulla oblongata. However, suggestive evidence has been obtained that this line of thought was valid. TRH was released in the rat medulla oblongata under basal conditions or when stimulated by K + (122). The ICV injection of a specific antibody to TRH decreased gastric acid secretion (123, 124) and TSH release in rats exposed to cold (125, 126), and averted gastric erosion produced by cold restraint (126).
TRH Stimulates Acid Secretion From Additional Brain Sites Therefore, considerable evidence has been accumulated that TRH and its analogue increased gastric acid, acetylcholine, histamine, and 5-HT secretion, and incited slow gastric contractions and gastric erosions when injected IC, ICV, or into the DMV and NA. Many of the same effects have been produced by electrically stimulating, or by the injection of RX 77368 near the nerve cell bodies of the medullary raphe nuclei whose axons terminate in the DMV (84, (127) (128) (129) (130) .
Thyrotropin-releasing hormone also increased gastric acid secretion and contractions when injected into the ventromedial (VMH), lateral (LH), and paraventricular (PVN) nuclei of the hypothalamus (131, 132) and the central nucleus of the amygdala (133). However, much larger doses of TRH were needed to produce the same effect than were required when the DMV was microinjected.
Corticotrop in -Releasing Hormone (CRH), Stressful Experience, Gastric Function, and Erosions Corticotrop in-releasing hormone is a 41-amino acid peptide (134, 135) . It is chemically identical in rats and humans (136) . The peptide is widely distributed throughout the brain and the body. The largest concentration of CRH in the brain is contained in the perikarya of neurons in the medial parvocellular portion of the PVN, whose axons pass to the median eminence where it is released into the portal circulation of the pituitary gland (137) (138) (139) . Corticotropin-containing neurons, terminals, and receptors are present throughout the brain-in the forebrain, amygdala, central gray matter, the locus ceruleus, the dorsal tegmental and parabrachial nuclei, NTS, DVM, and NA, the A a and A 2 nuclear complexes of the medulla-as well as in preganglionic sympathetic neurons of the spinal cord (139) (140) (141) (142) (143) (144) 146) . Of particular note is the direct neuronal pathway from the PVN to the locus ceruleus, to the NTS and the DVM whose transmitter is oxytocin (145, 146) . The peptide has also been identified in the adrenal medulla, liver, lung, stomach, duodenum, and pancreas (147-150).
Release of CRH During Stressful Experiences
Immunoreactive CRH was not usually detectable in the blood serum of rats and humans under normal and some life-threatening or stressful experiences (151) (152) (153) . However, its concentrations increased from baseline levels in the hypophysial portal circulation, and in the adrenal venous blood of rats and dogs during and after hemorrhage, and during exposure to cold (151, 153, 154) .
Acute and chronically stressful experiences (for instance, cold restraint, restraint alone, unpredictable shock, or injury) altered the CRH content of the median eminejnce, the PVN, and other nuclei known to contain it (155, 156) . Unpredictable shock plus cold restraint at 4°C reduced CRH levels in the median eminence and DMV, but increased it in the periventricular nucleus and the locus ceruleus (155) .
Physiological Effects of CRH The CRH induces the secretion of the proopiomelanocortin gene products-ACTH, /3-endorphin, and so forth-from the anterior pituitary gland (134, 157, 158) . In addition, it has wide-ranging behavioral and bodily effects which cannot alone be ascribed to the secretion of the pituitary hormones. Of particular importance are its autonomic and metabolic effects: It stimulated sympathetic efferent, but reduced parasympathetic activity; glucagon, epinephrine, norepinephrine were secreted under its influence. But the secretion of the growth and luteinizing hormones were inhibited. It raised the heart rate and blood pressure. When injected into specific brain sites or ICV (in hypophysectomized animals), CRH diminished gastric acid secretion and emptying and small bowel transit and motility, but increased gastric and duodenal HCO^" secretion. It speeded up colonic transit (159) (160) (161) (162) . Virtually all of these changes in physiology can be reversed by the subsequent ICV injection of a specific CRH antagonist, a-helical CRH (158, (163) (164) (165) (166) .
CRH and Gastric Erosions
It is fairly certain that TRH was released when rats were cold restrained and their body temperature fell; TRH-injected IC or ICV incited gastric erosions. The CRH was also selectively secreted under these conditions, but it protected against the formation of erosions.
The injection of CRH into the lateral hypothalamus or ICV failed to incite gastric erosions (75, 167) . In fact, CRH (5 jag), injected ICV or into the ventromedial nucleus of the hypothalamus, reduced the extent of gastric erosions associated with cold restraint (137, 168, 169) . If CRH played a role in inciting such erosions (rather than attenuating them), its inhibition by the administration of a-helical CRH would be expected to reduce their severity; but this did not occur (168) . In fact, CRH seemed to have some of the exact opposite effects to TRH on gastroduodenal function! But the matter may not be quite as simple as just stated. The protective effect of ICV CRH did not seem to manifest itself in food-deprived animals (169), in fact it may have enhanced erosions (75) . (As already mentioned, the gastric erosions of food deprivation differed in location from those associated with restraint.)
These discrepancies may have been the result of not taking into account the ages of animals. Older rats tended to respond to CRH by mounting a diminished, acute corticosterone response compared to younger ones. Yet older animals had a more sustained corticosteroid elevation to stressful experiences (170) . The protective effect on the stomach of IV CRH against stress was seen only in younger animals (171) .
CRH and Gastric Acid Secretion
In rats and dogs, especially when challenged IC and ICV, CRH inhibited gastric acid secretion (142, 167, (172) (173) (174) (175) (176) (177) (178) , which was reversed by the administration of ICV (but not IV) a-helical CRH (178) (179) (180) . Intracisternal CRH also diminished increased gastric acid secretion in rats, stimulated by IV pentagastrin, or IC TRH (167) . In dogs, ICV CRH decreased only pentagastrin-not histamine-stimulated acid secretion (175) .
Adrenalectomy and ganglionic and a.,-and a 2 -noradrenergic blocking agents prevented the decrease in gastric acid secretion, suggesting that the central nervous system action of CRH was mediated by sympathetic, noradrenergic (but not adrenergic) means, probably by stimulating STS secretion. But the effects of CRH were not altered by vagotomy (see, however, Ref. 167) or hypophysectomy (175, 176, 180, 181) .
To complicate the matter further, vasopressin may have been another mediator of stress-promoted gastric acid secretion, and of that induced by CRH, because a specific vasopressin inhibitor reversed the suppression of acid secretion brought about by CRH (175, 176, (180) (181) (182) . Vasopressin secretion into the blood stream was promoted by CRH (176) and interacted with CRH to potentiate ACTH secretion (183) .
Although the specific sites of action in the brain of CRH to inhibit gastric secretion are not completely known, one likely place was the DMV. However, CRH also had the same effect when applied to the VMH (184, 185) , LH (167, 184) , and the PVN (184); the lowest dose of CRH was required when the latter was injected (184) . CRH was unique among peptides in diminishing gastric acid concentration, and at the same time stimulating the volume of gastric fluid, and gastric HCOJ production and concentration when injected into the three hypothalamic sites (but not when the IC or ICV routes were used) (173, 184, 185) .
CRH and Gastroduodenal Bicarbonate Secretion
The presence of HCO^~ in cells and its secretion into lumen of the stomach and duodenum, respectively, constitute a "first line of defense" against protons and their back-diffusion into mucosal cells (186) . Both in human duodenal ulcer diseases (187) , and in the cold-restrained rat given histamine (66), duodenal HCOJ secretion was reduced. Duodenal HCOJ secretion is regulated both locally and by vagal and sympathetic efferent activity. Increased vagal activity (eg, sham feeding, hypoglycemia, ICV TRH, and STS) stimulated HCO^ secretion (188) (189) (190) (191) in rats and dogs. Noradrenergic (eg, a 2 -sympathetic activity) inhibited it (192) (193) (194) .
Both IV and ICV CRH stimulated gastroduodenal HCO^ secretion-an effect that was counteracted by a-helical CRH (194, 195) . The secretory responses to CRH were similar to that produced by stressful experience (195) . However, the effect of CRH on HCOJ secretion was counterintuitive. If the peptide increased noradrenergic sympathetic discharge it should have reduced it, unless it acted through some other mediator. In fact, this is the case. No HCOJ secretory response in hypophysectomized rats occurred after CRH injection or in unoperated rats after the administration of naloxone. Conversely, the response was unaltered after sympathetic ganglionic blockade or adrenalectomy. By implication, IV or ICV CRH released j3-endorphin which stimulated duodenal HCOjj" secretion-an inference supported by the fact that the administration of this opioid peptide did produce such an effect (195) .
CRH and Gastric Motor Function
Immobilization of rats affected the complex function of gastric emptying in opposite ways. In restrained rats, emptying and passage through the small bowel were both delayed. Intracerebroventricular (but not IV) CRH reproduced these effects which were blocked by ICV (not IV) injection of a-helical CRH. The antagonist also abolished the delay in gastric emptying after stressful experiences (178, (196) (197) (198) (199) .
The effects of ICV CRH on emptying were mediated by increased sympathetic activity because they could be abolished by a ganglionic blocking agent (chlorisondamine) and by an a n -norepinephrine antagonist (198, 200) . ]However, other data suggest that the vagus nerve also participated in delaying emptying, or, at least, in abolishing slow contractions (201), or gastric cyclic migratory motor activity (202), after ICV CRH infusion.
Slow Gastric Contractions and CRH: Interaction with TRH Centrally administered CRH protected rats against gastric erosions, but the manner in which it does so is still not known. However, the peptide diminished the motility of the stomach and some of its normal rhythms. The slow gastric contractions in rats, produced by IC RX 77368, were reduced by IC CRH in a dose-dependent manner. The contractions, however, were suppressed only by IV CRH in 10 times the dose effective by the IC route. Large high amplitude contractions provoked by IC 2-deoxy-D-glucose were also abolished by IC but not IV CRH. But the contractions produced by continuous IV carbachol infusion remained unaltered either by IC or IV CRH (100 ng) (203) . These results strongly suggested that CRH inhibited only centrally stimulated contractions. Simultaneous microinjection of RX 77368 and CRH into the DMV failed to produce slow contractions (204) . Therefore, one site of inhibition of the action of RX 77368 by CRH was the DMV.
The IC doses of CRH required to suppress slow contractions were less by a factor of 10 than those necessary to suppress gastric acid secretion. The inference that could be drawn was that stimulated slow gastric contractions and acid secretion were reduced by CRH through an inhibition of vagal efferent activity in an differentiated manner (167, 201, 205) .
Additional Inhibitors of TRH and Its Analogue at the DMV: Bombesin and Interleukin-I/3
A number of peptides additional to CRH seemed to interact with TRH or its analogue at the level of the DMV.
Bombesin. This 14-amino acid peptide, originally isolated from the skin of amphibians, has a mammalian counterpart in gastrin-releasing peptide. Immunoreactivity and receptors for bombesin-like peptides occur in the hypothalamus, area postrema, dorsal vagal complex (206, 207) , stomach, and gut.
When injected IC, bombesin inhibited food intake and gastric acid secretion and emptying; prevented gastric erosions; lowered the body temperature; and stimulated grooming, motor activity, and epinephrine secretion (89, (208) (209) (210) . The PVN (211) , and DMV (212) seemed to be two of the sites of action of bombesin because, when injected there, it suppressed stimulated (by IC TRH analogue) gastric acid secretion (212) and slow contractions in a dosedependent manner, but not when they were elicited by IV carbachol (213) . Yet, IC bombesin inhibited IV pentagastrin-induced gastric acid secretion-an effect which was reversed by a specific bombesin antagonist iV-acetyl-GRP (20-26)-0-CH 3 (214) . The concentration (in pmol) of bombesin used to inhibit gastric secretion made it a more potent inhibitor weight for weight than CRH.
Interleukin-Ifi (IL-Ifi). IL-I/3 is a generic name for two cytokines, each with a molecular mass of 17 kDa, which share the same two receptors. (The receptors do not have intrinsic tyrosine kinase activity.) The IL-I/3 play a key role in inflammation but also in noninflammatory processes. They modulate pain, stimulate the release of CRH, promote slow wave sleep, and decrease food intake. Many different cell types both within (microglia, astrocytes, selected neurons, and microvascular endothelium) and outside (macrophages, monocytes, fibroblasts, and osteoblasts) the brain secrete IL-I/3, especially on stimulation by bacterial cell products (215, 216).
At the cellular level, IL-I secretion in the brain has been induced by substance P, and in return is regulated the secretion of transforming growth factor-/3, nerve and fibroblast growth factors. The mRNA for IL-^ has been identified in the VM, PVN, lateral and arcuate hypothalamic nuclei, olfactory bulb, cerebellar granule cells, hippocampus, and in glia. Interleukin-I receptors have been identified in the basolateral amygdala, hippocampus, anterior and medial dorsal thalamus, cerebellum, mesencephalic nucleus of cranial nerve V, and on 5-HT-containing neurons in the dorsal raphe nuclei.
Hypothalamic neurons that increased their firing rates in rats placed in a cold environment were also excited by IL-I/3 infusion. Blocking the IL-I receptor (II), inhibited a rise in body temperature produced by IL-I/3 (215, 217, 218); and the mRNA for IL-I/3 was induced in the brains of immobilized rats (219).
Interleukin-I/3 inhibited all gastric functions when injected ICV, IC, IV, or into the anterior preoptic nucleus and PVN in fentomolar quantities (220). Human recombinant IL-I/3 inhibited basal and stimulated gastric acid and pepsin secretion, gastric emptying, postprandial intestinal activity, and prevented gastric erosion formation induced by restraining rats, or IC injection of TRH (220-222). Additionally, murine recombinant IL-I/3 inhibited slow gastric contractions, promoted by microinjection of the TRH analogue into the DMV of rats. The suppressive effects of picogram amounts of IL-I/3 on contractions was reversed by IC injections of the IL-I receptor antagonist (223).
Although we are far from understanding when, where, or under what conditions IL-I/3, its receptor, and receptor antagonist are expressed, a provisional synthesis may be possible. Substance P was colocalized with TRH and 5-HT in nuclei raphe obscurus and profundus. Cold and restraint seemed to induce the expression of TRH-a potent activator of DMV efferent neurons. Serotonin and TRH potentiated each others' actions at the DMV. Substance P also induced IL-I/3 which stimulated CRH secretion (221), and all three counter-regulate the excitatory effects of TRH on vagal efferent discharge to the stomach.
The Role of Other Peptides in Gastric Function and Possibly in Erosion Formation
A number of additional peptides inserted into the brain, ICV, or IC are known to affect gastric function, in particular gastric acid secretion ( Table 1] . Specifically, STS, vasoactive intestinal peptide (VIP), gastrin, cholecystokinin, and oxytocin stimulated secretion, but have not, with the exception of VIP been shown to produce erosions. Conversely, calcitonin and its gene-related peptide, neuropeptide Y, neurotensin, the opioid peptides, insulin growth factor II, and platelet-activating factor inhibit gastric secretion (for review, see Refs. 224 and 225).
At this time, the realistic role of this multitude of peptides in erosion formation, except for TRH and CRH, has not been determined. For example, we still do not know whether the other peptides are released when body temperature falls, or whether they respond to stressful experiences. The effects of many of the peptides have been studied in rats, cats, ferrets, rabbits, and dogs (225). But their relevance to human peptic ulcers remains to be established.
THE TRANSDUCTION OF STRESSFUL PROCEDURES BY THE BRAIN
Despite a great deal of progress, we do not understand how the traditional experimental procedures are transduced by the brain to produce gastric erosions. Most of our information comes from neurophysiological studies of increased electrical activity of neurons in the medial, central, and lateral nuclei of the amygdala, and the bed nuclei of the stria terminalis of rats during the initial phase of restraint. However, in those rats that later developed erosions, a rebound inhibition of multiple neuronal units in the amygdala followed. Whereas in rats without erosions, the initial increase in neuronal discharge rates was followed by a return to the baseline rate. Reproducible, distinct patterns of neuronal activity were, therefore, produced by restraint, each correlated with erosion formation, or not (224, 225). Similar results have been obtained by sampling evoked neuronal activity in granule cells of the dentate gyrus of the hippocampus: it was suppressed by restraint, but only in erosion-susceptible rats.
Restraint also activated neurons in the anterior cingulate gyrus of rats (225). Exposure of animals to cold increased the activity of neurons in the VMN of the hypothalamus. And indirect evidence was obtained, implicating the central nucleus of the amygdala during activity stress (eg, see Ref. 226). Neurochemical changes in the brain have been described during various forms of stressful procedures. The highest levels of the principal metabolite of norepinephrine, 3-methoxy-4-hydroxyphenylethyleneglycol sulfate (MHPG-SOJ, occurred in all the major regions of the brain (from cerebral cortex to the lower brain stem) after rats were exposed to the activity stress procedure for 5 days. The levels of MHPG-SO 4 in these brain regions progressively increased day by day. The levels of MHPG-SO 4 attained (especially in the cerebral cortex, thalamus, hippocampus, and midbrain) were considerably higher than in rats exposed either to 16-hour restraint for 6 successive days, or 5 days of 1 hour each of electric shocks (227). One hour of restraining rats produced about the same increases in levels of MHPG-SO4 in all brain regions as did 1 hour of electrical shocks to the feet. But when fear was conditioned in rats, the levels were increased over those found in control animals but only in the amygdala, hypothalamus, and locus ceruleus (228). Therefore, regional changes in MHPG-S0 4 depended on the experimental procedure used.
The central nucleus of the amygdala sends axons directly to the dorsal vagal complex, and via the stria terminalis to the hypothalamus. The hypothalamus also receives direct input from the hippocampus through fimbria-fornix neurons which may, however, play an insignificant role in gastric erosion formation. The ventral subiculum of the hippocampus directly connects to the central nucleus of the amygdala and may be the more relevant pathway in the production of gastric erosions (225).
By electrical stimulation, placing lesions, microinjection of peptides and of biogenic amines, or the use of their receptor antagonists, it has been possible to trace out the neuronal pathways involved in the regulation of gastric acid, pepsin, bicarbonate, and serotonin secretion, the stimulation of gastric motility, and in the production of gastric erosions. That circuitry is displayed in Figure 2 (229) . The validity of these neuronal arrangements (Table 2 ) has partly been established by the injections of TRH and CRH (230-232), but not for most of the other peptides previously mentioned.
The final common pathway in the process of gastric erosion formation is the DMV and NA and their preganglionic vagal efferent fibers. But the sympathetic nervous system, and the hormones of the pituitary and adrenal glands also participate in 
" Key: CRH, corticotropin-releasing factor; CAS, gastric acid secretion; GC, gastric contractions; CE, gastric erosions; HCOJ, bicarbonate secretion; 5-HT, serotonin secretion; and TRH, thyrotropin-releasing hormone.
the regulation of gastric acid secretion and, possibly in erosion formation. In fact, the matter is even more complex that Figure 1 portrays. For example, TRH injected into the DMV inhibited vagal afferent activity mediated through the overlying NTS (112, 113). Furthermore, the pituitary gland stimulated by CRH also regulates H + secretion by the stomach by releasing j8-endorphin and arginine vasopressin. Further credence to this belief was given by the fact that CRH injected into the PVN in nanogram doses inhibited gastric acid secretion and stimulated HCOJ secretion-effects that were reversed by the CRH antagonist. Injection of CRH into the VMH had the same effects, and also averted gastric erosions produced by 4 hours of cold restraint (184) . Lateral hypothalamic lesions were followed by increased basal acid secretion, slow gastric contractions and gastric erosions (58) . Microinjection of LH with CRH also inhibited gastric acid and promoted HCOJ secretion (167, 184) . Injection of these two hypothalamic nuclei with TRH-stimulated gastric acid secretion (131).
Injection of TRH into the central nucleus of the amygdala when rats were cold restrained (4°C) enhanced the number and severity of erosions. (Their severity was also markedly reduced by dopamine and neurotensin (230) .) The effect of TRH was abolished by methyl atropine, suggesting that it was mediated by the vagus nerve (224, 230).
Left out of the foregoing account is the possibility that, once injured, the repair of the gastroduodenal mucosa was impaired when a rat was subjected to "stressful" procedures. Gastrin enhanced the regeneration and/or repair of mucosal cells by stimulating DNA synthesis (233, 234). Mediated by gastrin secretion, the vagus nerve seemingly played a trophic role in mucosal growth and regeneration. Support for this notion came from the demonstration that in dogs when subjected to chronic sham feeding, which stimulated maximal gastric acid output by vagal means, an increased density of the gastric parietal and chief cells was produced (235).
In addition to gastrin, epidermal growth factor (EGF) and transforming growth factor-/3 (TGF-/3) also stimulated the growth of the gastroduodenal mucosa (236). When the bodily source of EGF was removed, rats were more susceptible to stress-induced erosions, which were prevented in other experiments by EGF administration (237, 238) . This growth factor also accelerated the healing of erosions (237, 239) , as did basic fibroblast growth factor when duodenal ulcers were incited in rats by cysteamine (240) . A promising line of animal research might well be to determine whether stressful experiences influence the induction or secretion of growth factors.
VALIDITY OF ANIMAL MODELS FOR HUMAN GASTRODUODENAL ULCERATION
For many years gastroenterologists have questioned the validity of animal models for human peptic ulceration (241) and have focused their attention on proximal pathogenetic mechanisms (242) , rather than on the distal ones-the roles of stressful experimental procedures, their transduction by the brain, and the brain's capacity to alter gastric function to produce erosions. The doubts of gastroenterologists have been heightened recently by the discovery of the association of gastroduodenal H. pylori infection with gastric and duodenal ulcers (243) , while neglecting several conceptual problems that this approach has posed.
In about 80% of all older patients with peptic ulcer this bacterium has been isolated from the stomach (244) . In 93%, specific antibodies against it can be detected in the serum of older hospitalized patients with gastric ulcer, and in 92% with duodenal ulcer. But, the authors of these studies neglected the meaning of the fact that in 78% of the control subjects without any disease, the same serum antibodies could be detected. They stated that the odds ratio of developing the two forms of peptic ulcer were increased when the specific antibodies against H. pylori were present in the serum of patients (245) . Another issue has been understated. The presence of H. pylori in the stomach has been associated with a number of other symptoms and diseases: dyspepsia (246) , active gastritis and duodenitis (247) , gastric carcinoma (248) , and non-Hodgkin's gastric lymphoma (249). Therefore, the bacterium lacks pathogenetic specificity.
The argument for its pathogenic role in peptic ulcer has been strengthened by the observation that treatment with a combination of an antibiotic (eg, tetracycline), bismuth subsalicylate, and metronidazole, designed to eradicate H. pylori from the stomach and duodenum, healed peptic ulcer disease in 74% and 95% of patients, respectively (250) . However, 75% of patients with duodenal ulcer in one series responded favorably to placebo without the disappearance of the infection-a statistically significant lower rate than in those given combined treatment. And an occasional patient, in whom the bacterium had been eradicated, later had a recurrence of a peptic ulcer (251) .
Therefore, one may conclude that H. pylori plays some role in the pathogenesis of peptic ulcer and gastritis. Intentional ingestion of the bacterium did produce an acute gastritis (252), but not ulceration. The question has remained how the infection contributed to the pathogenesis of gastritis and ulceration. Patients with this infection had excessive gastrin responses to the eating of a meal, as a result of which they had higher gastric acid secretion rates than noninfected subjects (253) . Even when no ulcer was present, infected subjects responded with higher serum gastrin levels to meals than did noninfected ones (254) . In addition, infection has been shown to raise pepsinogen-I levels, which fell with antibiotic treatment (255) . Infection was also associated with a lowering of hydrophobicity of the gastric mucus layer due probably to an endopeptidase secreted by H. pylori. Treatment restored the composition of the mucus (255) .
The bacterium has been found to secrete a protein cytotoxin (256) and a chemotactic factor (257) which may incite an inflammatory response and gastric mucosal metaplasia (258) . The fact that serum antibodies against H. pylori were produced suggested that immunocompetent cells in the lamina propria of the stomach wall mount an immune response. The role of these cells has been much neglected in the study of gastroduodenal disease. They expressed mRNAs for histamine (H-2), gastrin, muscarinic (M.,_ 5 ) acetylcholine, and dopamine (D^) receptors, which parietal cells did not seem to (259) . Therefore, immunocytes (eg, macrophages, monocytes, CD4 + cells, and so forth) may be activated by infection and secrete gastrin, histamine, and so forth.
Presumably, H. pylori by raising gastrin secretion increased gastric acid and pepsin production, impaired mucus protection, and incited metaplasia and inflammation, leading to gastritis, duodenitis, and peptic ulceration. However, the pathogenetic mechanisms responsible for gastric non-Hodgkins lymphoma and adenocarcinoma have remained unexplained.
Most (80%) normal peoples' stomachs are colonized by H. pylori, yet only 1-2% ever developed peptic ulcers (243) (244) (245) (246) (247) (248) (249) (250) (251) (252) (253) (254) (255) . Therefore, the bacterium may be necessary but not sufficient for one form of the disease, leaving room for many other contributing factors including psychosocial ones. Thus peptic ulcers remain a multifactorial and heterogenous group of diseases (1, 255).
SUMMARY
This review does not fulfill the promise that an animal model would account for the pathogenesis of human peptic ulceration. The main impediment to providing such an explanation is that the processes which culminate in ulceration are so complex. Even the usual regulatory processes underlying the physiology of the stomach-for example, a function as simple as hydrogen ion production and secretionresult from multiple feedback processes in interaction with each other (Figure l) . Because of the number of interacting variables, many different combinations of antecedent pathogenetic processes are possible, or even likely.
The immediate antecedents of erosion formation seem to be back-diffusion of protons into mucosal cells, occurring when a variety of protective factors (eg, 5-HT, HCOJ, and mucus secretion) were diminished. However, in rats another essential condition must be met-slow gastric contractions which seem to damage the .mucosa by unknown means.
The discovery that in many experimental models of erosion formation in rats, the body temperature fell, and when prevented, no lesions occurred, has accelerated progress. Because TRH was secreted in the brain of rats exposed to cold, much effort has been expended in verifying that TRH did indeed incite acid secretion and erosions when injected into DMV, PVN, and amygdala. Slow gastric contractions were generated with DMV injections of TRH or its analogue. But TRH also incited gastric 5-HT and HCOJj" secretion to counteract acid secretion.
Thus it is likely that TRH secretion participated in the cold restraint model, in which gastric acid secretion was usually increased. Yet it was not always so (9, 50, 51). Thus the pathogenesis of erosions on cold restraint has not been fully explained. Nonetheless, exposure to cold also promoted CRH secretion. When CRH was injected into the VMH, it attenuated damage to the gastric mucosa after 4 hours of cold restraint. When injected IC and into the DMV, CRH also abolished stimulated slow gastric contractions, inhibited gastric emptying, and increased HCOŝ ecretion into the stomach lumen, thereby raising its pH (185) . Therefore, during cold restraint, a spectrum of acid secretory responses may have occurred, brought about by the relative predominance either of TRH or CRH.
To add further to the problem, TRH incited proton secretion only through the release of acetylcholine and histamine. But CRH also increased serum gastrin levels in rats (185) and incited gastric STS release, known to inhibit both gastrin and histamine secretion.
Much progress has been made in the past years in providing some support to the idea that gastric erosions can be brought about by stressful experiences mediated by the brain. Some of the brain circuitry translating such experiences has been mapped-for example, the central nucleus of the amygdala, PVN, VMH, and LH nuclei, and the DMV and NA. Many of these nuclei are monosynaptically connected. And each of them are responsive in opposite directions to TRH and CRH to alter the principal gastric functions. 
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